Baralić, M.; Stojanović, N.; Gajić, S.; Sič, A.; Manzar, A.; Bontić, A.; Pavlović, J.; Bojić, M.N.; Kezić, A.
Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality. Vaccines 2025, 13, 723.
https://doi.org/10.3390/vaccines13070723
AMA Style
Baralić M, Stojanović N, Gajić S, Sič A, Manzar A, Bontić A, Pavlović J, Bojić MN, Kezić A.
Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality. Vaccines. 2025; 13(7):723.
https://doi.org/10.3390/vaccines13070723
Chicago/Turabian Style
Baralić, Marko, Nikola Stojanović, Selena Gajić, Aleksandar Sič, Aarish Manzar, Ana Bontić, Jelena Pavlović, Mateja N. Bojić, and Aleksandra Kezić.
2025. "Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality" Vaccines 13, no. 7: 723.
https://doi.org/10.3390/vaccines13070723
APA Style
Baralić, M., Stojanović, N., Gajić, S., Sič, A., Manzar, A., Bontić, A., Pavlović, J., Bojić, M. N., & Kezić, A.
(2025). Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality. Vaccines, 13(7), 723.
https://doi.org/10.3390/vaccines13070723